A Phase 1b/2 Study of YL-13027 Combined With Sintilimab in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Advanced Solid Tumors
Related studies linked through entity extraction aliases.
A Phase 1/ 2, First-in-Human, Open-Label, Accelerated-Titration, Two-Part Clinical Trial of TK-8001 in Patients With HLA-A*02:01 Genotype and Advanced-Stage/ Metastatic MAGE-A1+ Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of MK-1088 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-1088-002)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Efficacy and Safety of AK127 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of KL340399 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection
- Status
- COMPLETED
- Phase
- PHASE1
A Study of SKB315 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Trial of the Combination of SHR-A1811 and Fluzoparib in HER2-Expressing Cancers
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Study of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
A Study of QLS31905 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
TT-702 in Patients With Advanced Solid Tumours.
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase I First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WGI-0301 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1